cromolyn sodium inhalation solution
Generic: cromolyn sodium inhalation solution
Labeler: ritedose pharmaceuticals, llcDrug Facts
Product Profile
Brand Name
cromolyn sodium inhalation solution
Generic Name
cromolyn sodium inhalation solution
Labeler
ritedose pharmaceuticals, llc
Dosage Form
SOLUTION
Routes
Active Ingredients
cromolyn sodium 20 mg/2mL
Manufacturer
Identifiers & Regulatory
Product NDC
76204-028
Product ID
76204-028_459fa0f5-35dd-d6e5-e063-6394a90a6f14
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209453
Listing Expiration
2026-12-31
Marketing Start
2021-12-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76204028
Hyphenated Format
76204-028
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cromolyn sodium inhalation solution (source: ndc)
Generic Name
cromolyn sodium inhalation solution (source: ndc)
Application Number
ANDA209453 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/2mL
Packaging
- 2 POUCH in 1 CARTON (76204-028-60) / 30 AMPULE in 1 POUCH (76204-028-12) / 2 mL in 1 AMPULE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "459fa0f5-35dd-d6e5-e063-6394a90a6f14", "openfda": {"unii": ["Q2WXR1I0PK"], "rxcui": ["831246"], "spl_set_id": ["0209cd6c-5c43-0b93-e063-6294a90ac964"], "manufacturer_name": ["Ritedose Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 POUCH in 1 CARTON (76204-028-60) / 30 AMPULE in 1 POUCH (76204-028-12) / 2 mL in 1 AMPULE", "package_ndc": "76204-028-60", "marketing_start_date": "20211201"}], "brand_name": "Cromolyn Sodium Inhalation Solution", "product_id": "76204-028_459fa0f5-35dd-d6e5-e063-6394a90a6f14", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "76204-028", "generic_name": "Cromolyn Sodium Inhalation Solution", "labeler_name": "Ritedose Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cromolyn Sodium Inhalation Solution", "active_ingredients": [{"name": "CROMOLYN SODIUM", "strength": "20 mg/2mL"}], "application_number": "ANDA209453", "marketing_category": "ANDA", "marketing_start_date": "20211201", "listing_expiration_date": "20261231"}